form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
 
 
FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 
Date of Report (Date of earliest event reported):  February 26, 2008
 
Orthofix International N.V.
(Exact name of Registrant as specified in its charter)
 
Netherlands Antilles
  
0-19961
  
N/A
(State or other jurisdiction of incorporation)
  
Commission File Number
  
(I.R.S. Employer Identification Number)
 
 
 
7 Abraham de Veerstraat
      
 
Curaçao
      
 
Netherlands Antilles
  
N/A
  
 
(Address of principal executive offices)
  
(Zip Code)
  

Registrant’s telephone number, including area code:  011-59-99-465-8525
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
 
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
£
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
Item 7.01.
Regulation FD Disclosure.

On February 26, 2008 Orthofix International N.V. (the “Company”) issued a press release that provides, among other things, guidance for certain projected financial results for the Company for the first quarter and full year of 2008.  A copy of the press release is furnished herewith as Exhibit 99.1 and attached hereto.
 
This information shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth in the specific reference in such a filing.
 

Item 9.01.
Financial Statements and Exhibits
 
 
(c)
Exhibits

 
Press release of Orthofix International N.V. dated February 26, 2008.

 
 
 

SIGNATURE
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
   
ORTHOFIX INTERNATIONAL N.V.
     
     
Dated:  February 26, 2008
  
By: 
/s/ Timothy M. Adams
     
Name: 
Timothy M. Adams
     
Title:
Chief Financial Officer